Share trading in Yourgene has been suspended as a £16.7 million takeover by an international diagnostics business goes through. The Manchester-headquartered MedTech company, listed on the London Stock Exchange’s AIM market, is to join Novacyt UK, a wholly-owned subsidiary of Novacyt. Novacyt delivers a broad portfolio of in vitro and molecular diagnostic tests – including PCR … Continue reading Yourgene shares suspended amid £16.7m takeover